Statement of Organization, Functions, and Delegations of Authority, 1446 [06-144]
Download as PDF
cprice-sewell on PROD1PC66 with NOTICES
1446
Federal Register / Vol. 71, No. 5 / Monday, January 9, 2006 / Notices
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Building 31, 31 Center Drive, Conference
Room 10, Bethesda, MD 20892.
Open: February 16, 2006, 8:30 a.m. to 9:30
a.m.
Agenda: Continuation of the review of the
Division’s scientific and planning activities.
Place: National Institutes of Health,
Building 31, 31 Center Drive, Conference
Room 10, Bethesda, MD 20892.
Contact Person: Brent B. Stanfield, PhD,
Director, Division of Extramural Activities,
National Institute of Diabetes and Digestive
and Kidney Diseases, 6707 Democracy Blvd.,
Room 715, Bethesda, MD 20892. (301) 594–
8843. stanfieldb@extra.niddk.nih.gov.
Name of Committee: National Diabetes and
Digestive and Kidney Diseases Advisory
Council, Digestive Diseases and Nutrition
Subcommittee.
Date: February 15–16, 2006.
Open: February 15, 2006, 1 p.m. to 3 p.m.
Agenda: To review the Division’s scientific
and planning activities.
Place: National Institutes of Health,
Building 31, 31 Center Drive, Conference
Room 9A22, Bethesda, MD 20892.
Closed: February 15, 2006, 3:15 p.m. to
5:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Building 31, 31 Center Drive, Conference
Room 9A22, Bethesda, MD 20892.
Open: February 16, 2006, 8 a.m. to 9:30
a.m.
Agenda: Continuation of the review of the
Division’s scientific and planning activities.
Place: National Institutes of Health,
Building 31, 31 Center Drive, Conference
Room 9A22, Bethesda, MD 20892.
Contact Person: Brent B. Stanfield, PhD,
Director of Extramural Activities, National
Institute of Diabetes and Digestive and
Kidney Diseases, 6707 Democracy Blvd.,
Room 715, Bethesda, MD 20892. (301) 594–
8843. stanfieldb@extra.niddk.nih.gov.
Name of Committee: National Diabetes and
Digestive and Kidney Diseases Advisory
Council, Kidney, Urologic, and Hematologic
Diseases Subcommittee.
Date: February 15–16, 2006.
Open: February 15, 2006, 1 p.m. to 5:30
p.m.
Agenda: To review the Division’s scientific
and planning activities.
Place: National Institutes of Health,
Building 31, 31 Center Drive, Conference
Room, Bethesda, MD 20892.
Closed: February 16, 2006, 8 a.m. to 9:30
a.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Building 31, 31 Center Drive, Conference
Room 7, Bethesda, MD 20892.
Contact Person: Brent B. Stanfield, PhD,
Director, Division of Extramural Activities,
National Institute of Diabetes and Digestive
and Kidney Diseases, 6707 Democracy Blvd.,
Room 715, Bethesda, MD 20892. (301) 594–
8843. stanfieldb@extra.niddk.nih.gov.
Any interested person may file written
comments with the committee by forwarding
VerDate Aug<31>2005
15:31 Jan 06, 2006
Jkt 208001
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has
instituted stringent procedures for entrance
into the building by non-government
employees. Persons without a government
I.D. will need to show a photo I.D. and sign
in at the security desk upon entering the
building.
Information is also available on the
Institute’s/Center’s home page: https://
www.niddk.nih.gov/fund/divisions/DEA/
Council/coundesc.htm., where an agenda and
any additional information for the meeting
will be posted when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.847, Diabetes,
Endocrinology and Metabolic Research;
93.848, Digestive Diseases and Nutrition
Research; 93.849, Kidney Diseases, Urology
and Hematology Research, National Institutes
of Health, HHS)
Dated: December 29, 2005.
Anna Snouffer,
Acting Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 06–143 Filed 1–6–06; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
collaboration and cooperation between
the NIH and the surrounding
community; (3) conducts and oversees
studies, projects, and evaluations
designed to address problems,
questions, and issues of community
concern and environmental impact; (4)
ensures that NIH activities affecting the
surrounding community involve
community representation at all levels
of design, review, and implementation;
and (5) ensures effective communication
and collaboration on policy and
programs involving the surrounding
community between the Office of the
Director, NIH, and operating
components of the NIH.
(2) Delete the Office of Community
Liaison (NAP, formerly HNAP) in its
entirety.
Delegations of Authority: All
delegations and redelegations of
authority to officers and employees of
NIH that were in effect immediately
prior to the effective date of this
amendment and are consistent with this
amendment shall continue in effect,
pending further redelegation.
Dated: November 4, 2005.
Elias A. Zerhouni,
Director, National Institutes of Health.
[FR Doc. 06–144 Filed 1–6–06; 8:45 am]
BILLING CODE 4140–01–M
National Institutes of Health
Statement of Organization, Functions,
and Delegations of Authority
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Part N, National Institutes of Health,
of the Statement of Organization,
Functions, and Delegations of Authority
for the Department of Health and
Human Services (HHS) (40 FR 22859,
May 27, 1975, as amended most recently
at 69 FR 64081, November 3, 2004, and
redesignated from Part HN as part N at
60 FR 56606, November 9, 1995), is
amended as set forth below to reflect the
reorganization of the Office of the
Director, NIH, by transferring the Office
of Community Liaison from the Office of
the Director (OD) to the Office of
Communications and Public Liaison,
OD.
Section N–B, Organization and
Functions, under the heading Office of
the Director (NA, formerly HNA), is
amended as follows:
(1) Under the heading Office of
Communications and Public Liaison
(NA8, formerly HNA8) insert the
following:
Office of Community Liaison (NA85,
formerly HNA85). (1) Advises the NIH
Director on policies, programs, and
issues involving the NIH and the
surrounding community; (2) plans and
directs activities to promote
National Institutes of Health
PO 00000
Frm 00041
Fmt 4703
Sfmt 4703
Statement of Organization, Functions,
and Delegations of Authority
Part N, National Institutes of Health,
of the Statement of Organization,
Functions, and Delegations of Authority
for the Department of Health and
Human Services (HHS) (40 FR 22859,
May 27, 1975, as amended most recently
at 70 FR 61146, October 20, 2005, and
redesignated from Part HN as Part N at
60 FR 56606, November 9, 1995), is
amended as set forth below to reflect the
reorganization of the NIH Ethics Office.
Section N-B, Organization and
Functions, under the heading Office of
the Director (NA, formerly HNA), is
amended as follows:
Replace the current section NAT
(formerly HNAT) with the following:
NIH Ethics Office (NAT, formerly
HNAT). (1) Provides oversight and
strategic direction of NIH activities
relating to ethics policy, oversight, and
operational activities; (2) develops and
administers the NIH policies and
procedures for implementing the
Government-wide conflict of interest
statutes and regulations, the HHS
E:\FR\FM\09JAN1.SGM
09JAN1
Agencies
[Federal Register Volume 71, Number 5 (Monday, January 9, 2006)]
[Notices]
[Page 1446]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 06-144]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Statement of Organization, Functions, and Delegations of
Authority
Part N, National Institutes of Health, of the Statement of
Organization, Functions, and Delegations of Authority for the
Department of Health and Human Services (HHS) (40 FR 22859, May 27,
1975, as amended most recently at 69 FR 64081, November 3, 2004, and
redesignated from Part HN as part N at 60 FR 56606, November 9, 1995),
is amended as set forth below to reflect the reorganization of the
Office of the Director, NIH, by transferring the Office of Community
Liaison from the Office of the Director (OD) to the Office of
Communications and Public Liaison, OD.
Section N-B, Organization and Functions, under the heading Office
of the Director (NA, formerly HNA), is amended as follows:
(1) Under the heading Office of Communications and Public Liaison
(NA8, formerly HNA8) insert the following:
Office of Community Liaison (NA85, formerly HNA85). (1) Advises the
NIH Director on policies, programs, and issues involving the NIH and
the surrounding community; (2) plans and directs activities to promote
collaboration and cooperation between the NIH and the surrounding
community; (3) conducts and oversees studies, projects, and evaluations
designed to address problems, questions, and issues of community
concern and environmental impact; (4) ensures that NIH activities
affecting the surrounding community involve community representation at
all levels of design, review, and implementation; and (5) ensures
effective communication and collaboration on policy and programs
involving the surrounding community between the Office of the Director,
NIH, and operating components of the NIH.
(2) Delete the Office of Community Liaison (NAP, formerly HNAP) in
its entirety.
Delegations of Authority: All delegations and redelegations of
authority to officers and employees of NIH that were in effect
immediately prior to the effective date of this amendment and are
consistent with this amendment shall continue in effect, pending
further redelegation.
Dated: November 4, 2005.
Elias A. Zerhouni,
Director, National Institutes of Health.
[FR Doc. 06-144 Filed 1-6-06; 8:45 am]
BILLING CODE 4140-01-M